<--- Back to Details
First PageDocument Content
Medicine / Health / Clinical medicine / RTT / Epidemiology / Gastrointestinal cancer / Pancreatic cancer / Oncology / Survival rate / Relative survival / Five-year survival rate / Cancer
Date: 2013-12-16 04:46:49
Medicine
Health
Clinical medicine
RTT
Epidemiology
Gastrointestinal cancer
Pancreatic cancer
Oncology
Survival rate
Relative survival
Five-year survival rate
Cancer

NICER Trends in Pancreatic Cancer Survival in Switzerland Michael Montemurro1, Matthias Lorez2 and the NICER Working Group§ 1

Add to Reading List

Source URL: www.nicer.org

Download Document from Source Website

File Size: 213,59 KB

Share Document on Facebook

Similar Documents

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Formal Specication and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document